Immunocompatibility and biocompatibility of cell delivery systems

Advanced Drug Delivery Reviews

Volumn 42, Issue 1-2, 2000, Pages 65-80

  Říhová, Blanka ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Antibody; Autoimmunity; Biocompatibility; Cell adhesion; Complement; Cytokines; Encapsulation; Immune response; Immunocompatibility; Immunoglobulin; Immunoisolation; Immunoprotection; Inflammatory response; Polymer implants; Polymeric materials; Transplantation

Indexed keywords

ABSORPTION; BIOCOMPATIBILITY; BIOMATERIALS; CELLS; CYTOLOGY; ENCAPSULATION; IMMUNOLOGY; IMPLANTS (SURGICAL); POLYMERS; PROTEINS; TRANSPLANTATION (SURGICAL);

ALLOGRAFTS; AUTOANTIBODIES; CELL DELIVERY SYSTEMS; IMMUNOCOMPATIBILITY; IMMUNOISOLATION THERAPY; XENOGRAFTS;

CONTROLLED DRUG DELIVERY;

ALGINIC ACID; COMPLEMENT; COPOLYMER; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN; POLYLYSINE; POLYMER;

ADSORPTION; ALLOGRAFT; ANIMAL MODEL; AUTOIMMUNITY; BIOCOMPATIBILITY; CELL; CELL ADHESION; CELL GROWTH; DEVICE; DIFFUSION; DRUG DELIVERY SYSTEM; ENCAPSULATION; FIBROBLAST; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; STREPTOZOCIN DIABETES; TRANSPLANTATION; XENOGRAFT;

EID: 0034692121     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00054-5     Document Type: Article

References (130)

1. Chang T.M.S. Semipermeable microcapsules. Science. 146:1964;524-525.
2. Briššová M., Petro M., Lacík I., Powers A.C., Wang T. Evaluation of microcapsule permeability via inverse size exclusion chromatography. Anal. Biochem. 242:1996;104-111.
3. Lum Z.P., Tai I.T., Krestow M., Norton J., Vacek I., Sun A.M. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes. 40:1991;1511-1516.
4. Lum Z.P., Krestow M., Tai I.T., Vacek I., Sun A.M. Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules. Transplantation. 53:1992;1180-1183.
5. O'Shea G.M., Sun A.M. Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. Diabetes. 35:1986;943-946.
6. Wang T., Lacík I., Briššová M., Anilkumar A.V., Prokop A., Hunkeler D., Green R., Shahrokhi K., Powers A.C. An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 15:1997;358-362.
7. Lanza R.P., Hayes J.L., Chick W.L. Encapsulated cell technology. Nat. Biotechnol. 14:1996;1107-1111.
8. Lanza R.P., Chick W.L. Transplantation of encapsulated cells and tissues. Surgery. 121:1997;1-9.
9. Sawhney A.S., Hubbell J.A. Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes. Biomaterials. 13:1992;863-870.
10. Uludag H., Hwang J.R., Sefton M.V. Microencapsulated human hepatoma (HepG2) cells: capsule-to-capsule variations in protein secretion and permeability. J. Control. Release. 33:1995;273-283.
11. Uludag H., Sefton M.V. Microencapsulated human hepatoma (HepG2) cells: in vitro growth and protein release. J. Biomed. Mater. Res. 27:1993;1213-1224.
12. O'Shea G.M., Goosen M.F., Sun A.M. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim. Biophys. Acta. 804:1984;133-136.
13. Smidrood O., Skjak-Braek G. Alginate as immobilization matrix for cells. Tibtech. 8:1990;71.
14. Soon-Shiong P., Feldman E., Nelson R., Heintz R., Merideth N., Sandford P., Zheng T., Komtebedde J. Long-term reversal of diabetes in the large animal model by encapsulated islet transplantation. Transplant. Proc. 24:1992;2946-2947.
15. Norton J., Sun A.M. Delivery of insulin or novel gen product through encapsulated pancreatic B cells or recombinant cells. Workshop - Bioencapsulation a Key to the Bioindustries, Paris :1992.
16. Clayton H.A., James R.F., London N.J. Islet microencapsulation: a review. Acta Diabetol. 30:1993;181-189.
17. Zekorn T., Siebers U., Horcher A., Schnettler R., Klöck G., Bretzel R.G., Zimmermann U., Federlin K. Barium-alginate beads for immunoisolated transplantation of islets of Langerhans. Transplant. Proc. 24:1992;937-939.
18. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:1980;908-910.
19. Kessler L., Aprahamian M., Keipes M., Damge C., Pinget M., Poinsot D. Diffusion properties of an artificial membrane used for Langerhans islets encapsulation: an in vitro test. Biomaterials. 13:1992;44-49.
20. Lacy P.E., Hegre O.D., Gerasimidi Vazeou A., Gentile F.T., Dionne K.E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science. 254:1991;1782-1784.
21. Rivereau A.S., Darquy S., Chaillous L., Maugendre S., Gouin E., Reach G., Sai P. Reversal of diabetes in non-obese diabetic mice by xenografts of porcine islets entrapped in hollow fibres composed of polyacrylonitrile-sodium methallylsulphonate copolymer. Diabetes Metab. 23:1997;205-212.
22. Fritschy W.M., Strubbe J.H., Wolters G.H., van Schilfgaarde R. Glucose tolerance and plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islet allografts. Diabetologia. 34:1991;542-547.
23. De Vos P., Wolters G.H., Fritschy W.M., Van Schilfgaarde R. Obstacles in the application of microencapsulation in islet transplantation. Int. J. Artif. Organs. 16:1993;205-212.
24. Iwata H., Takagi T., Kobayashi K., Oka T., Tsuji T., Ito F. Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. J. Biomed. Mater. Res. 28:1994;1201-1207.
25. Klöck G., Siebers U., Pfeffermann A., Schmitt J., Houben R., Federlin K., Zimmermann U. Immunoisolation of transplanted islets of Langerhans: microcapsules with controlled molecular weight cutoff. Immun. Infekt. 21:1993;181-184.
26. Joly A., Desjardins J.F., Fremond B., Desille M., Campion J.P., Malledant Y., Lebreton Y., Semana G., Edwards Levy F., Levy M.C., et al. Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver. Transplantation. 63:1997;795-803.
27. Sun A.M., Cai Z., Shi Z., Ma F., O'Shea G., Gharapetian H. Microencapsulated hepatocytes as a bioartificial liver. Trans. Am. Soc. Artif. Intern. Organs. 32:1986;39.
28. Chang T.M.S. Living cells and microorganisms immobilized by microencapsulation inside artificial cells. Goosen M.F.A. Fundamentals of Animal Cell Encapsulation and Immobilization. 1993;183 CRC Press, Boca Raton, FL.
29. Gupta S., Kim S.K., Vemuru R.P., Aragona E., Yerneni P.R., Burk R.D., Rha C.K. Hepatocyte transplantation: an alternative system for evaluating cell survival and immunoisolation. Int. J. Artif. Organs. 16:1993;155-163.
30. Roger V., Balladur P., Honiger J., Baudrimont M., Delelo R., Robert A., Calmus Y., Capeau J., Nordlinger B. Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study. Ann. Surg. 228:1998;1-7.
31. Hasse C., Zielke A., Klöck G., Schlosser A., Barth P., Zimmermann U., Sitter H., Lorenz W., Rothmund M. Amitogenic alginates: key to first clinical application of microencapsulation technology. World J. Surg. 22:1998;659-665.
32. Spenger C., Studer L., Evtouchenko L., Egli M., Burgunder J.M., Markwalder R., Seiler R.W. Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon. J. Neurosci. Methods. 54:1994;63-73.
33. Aebischer P., Tresco P.A., Winn S.R., Greene L.A., Jaeger C.B. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp. Neurol. 111:1991;269-275.
34. Joseph J.M., Goddard M.B., Mills J., Padrun V., Zurn A., Zielinski B., Favre J., Gardaz J.P., Mosimann F., Sagen J., et al. Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain. Cell Transplant. 3:1994;355-364.
35. Tresco P.A., Winn S.R., Tan S., Jaeger C.B., Greene L.A., Aebischer P. Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transplant. 1:1992;255-264.
36. Deglon N., Heyd B., Tan S.A., Joseph J.M., Zurn A.D., Aebischer P. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum. Gene Ther. 7:1996;2135-2146.
37. Sagot Y., Tan S.A., Baetge E., Schmalbruch H., Kato A.C., Aebischer P. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci. 7:1995;1313-1322.
38. Roberts T., De Boni U., Sefton M.V. Microencapsulation of dopamine secreting cells (PC12) in a HEMA-MMA copolymer. Trans. Soc. Biomater. 14:1991;157-165.
39. Lindner M.D., Winn S.R., Baetge E.E., Hammang J.P., Gentile F.T., Doherty E., McDermott P.E., Frydel B., Ullman M.D., Schallert T., et al. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp. Neurol. 132:1995;62-76.
40. Emerich D.F., Winn S.R., Lindner M.D. Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents. Cell Transplant. 5:1996;589-596.
41. Cheng W.T., Chen B.C., Chiou S.T., Chen C.M. Use of nonautologous microencapsulated fibroblasts in growth hormone gene therapy to improve growth of midget swine. Hum. Gene Ther. 9:1998;1995-2003.
42. Hortelano G., Al-Hendy A., Ofosu F.A., Chang P.L. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood. 87:1996;5095-5103.
43. Pizzorusso T., Porciatti V., Tseng J.L., Aebischer P., Maffei L. Transplant of polymer-encapsulated cells genetically engineered to release nerve growth factor allows a normal functional development of the visual cortex in dark-reared rats. Neuroscience. 80:1997;307-311.
44. Lanza R.P., Jackson R., Sullivan A., Ringeling J., McGrath C., Kuhtreiber W., Chick W.L. Xenotransplantation of cells using biodegradable microcapsules. Transplantation. 67:1999;1105-1111.
45. Granicka L.H., Kawiak J.W., Glowacka E., Werynski A. Encapsulation of OKT3 cells in hollow fibers. ASAIO J. 42:1996;M863-M866.
46. Chaillous L., Darquy S., Maugendre S., Rivereau A.S., Reach G., Sai P. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice. Diabetologia. 39:1996;523-529.
47. Říhová B., Říha I. Immunological problems of polymer-bound drugs. Crit. Rev. Ther. Drug Carrier Syst. 1:1985;311-374.
48. Klinkmann H., Falkenhagen D., Stefoni S., Bonomini V. Biocompatibility, a system approach. Contrib. Nephrol. 70:1989;213-226.
49. Gin H., Dupuy B., Bonnemaison Bourignon D., Bordenave L., Bareille R., Latapie M.J., Baquey C., Bezian J.H., Ducassou D. Biocompatibility of polyacrylamide microcapsules implanted in peritoneal cavity or spleen of the rat. Effect on various inflammatory reactions in vitro. Biomater. Artif. Cells Artif. Organs. 18:1990;25-42.
50. Miller K.M., Anderson J.M. Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. J. Biomed. Mater. Res. 22:1988;713-731.
51. Campioni E.G., Nobrega J.N., Sefton M.V. HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis. Biomaterials. 19:1998;829-837.
52. Soon-Shiong P., Feldman E., Nelson R., Komtebedde J., Smidsrod O., Skjak Braek G., Espevik T., Heintz R., Lee M. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation. 54:1992;769-774.
53. Gröhn P., Klöck G., Schmitt J., Zimmermann U., Horcher A., Bretzel R.G., Hering B.J., Brandhorst D., Brandhorst H., Zekorn T., et al. Large-scale production of Ba(2+)-alginate-coated islets of Langerhans for immunoisolation. Exp. Clin. Endocrinol. 102:1994;380-387.
54. Klöck G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., Wohrle M., Federlin K., Zimmermann U. Production of purified alginates suitable for use in immunoisolated transplantation. Appl. Microbiol. Biotechnol. 40:1994;638-643.
55. Geisen K., Deutschländer H., Gorbach S., Klenke C., Zimmermann U. Function of barium alginate-microencapsulated xenogenic islets in different diabetic mouse models. Shafrir E. Lessons From Animal Diabetes III, II. Frontiers in Diabetes Research. Vol. 8:1990;142-148.
56. Tatarkiewicz K. New membrane for cell encapsulation. Artif. Organs. 12:1988;446-448.
57. Soon-Shiong P., Feldman E., Nelson R., Heintz R., Yao Q., Yao Z., Zheng T., Merideth N., Skjak Braek G., Espevik T., et al. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc. Natl. Acad. Sci. USA. 90:1993;5843-5847.
58. Crooks C.A., Douglas J.A., Broughton R.L., Sefton M.V. Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability. J. Biomed. Mater. Res. 24:1990;1241-1262.
59. Goosen M.F.A. Lanza R.P., Chick W.L.K. Immunoisolation of Pancreatic Islets. 1994;21-44 R.G. Landes, Austin, TX.
60. Wang T.G. New technologies for bioartificial organs. Artif. Organs. 22:1998;68-74.
61. Briššová M., Lacík I., Powers A.C., Anilkumar A.V., Wang T. Control and measurement of permeability for design of microcapsule cell delivery system. J. Biomed. Mater. Res. 39:1998;61-70.
62. Lacík I., Briššová M., Anilkumar A.V., Powers A.C., Wang T. New capsule with tailored properties for the encapsulation of living cells. J. Biomed. Mater. Res. 39:1998;52-60.
63. Pueyo M.E., Darquy S., Capron F., Reach G. In vitro activation of human macrophages by alginate-polylysine microcapsules. J. Biomater. Sci. Polym. Ed. 5:1993;197-203.
64. Kulseng B., Skjak-Braek G., Ryan L., Andersson A., King A., Faxvaag A., Espevik T. Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation. 67:1999;978-984.
65. Soon-Shiong P., Otterlie M., Skjak Braek G., Smidsrod O., Heintz R., Lanza R.P., Espevik T. An immunologic basis for the fibrotic reaction to implanted microcapsules. Transplant. Proc. 23:1991;758-759.
66. Otterlei M., Ostgaard K., Skjak-Braek G., Smidsrod O., Soon-Shiong P., Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J. Immunother. 10:1991;286-291.
67. Iwata H., Kobayashi K., Takagi T., Oka T., Yang H., Amemiya H., Tsuji T., Ito F. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. J. Biomed. Mater. Res. 28:1994;1003-1011.
68. Kessler L., Pinget M., Aprahamian M., Dejardin P., Damge C. In vitro and in vivo studies of the properties of an artificial membrane for pancreatic islet encapsulation. Horm. Metab. Res. 23:1991;312-317.
69. Pelegrin M., Marin M., Noel D., Del-Rio M., Saller R., Stange J., Mitzner S., Gunzburg W.H., Piechaczyk M. Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells. Gene Ther. 5:1998;828-834.
70. Basmadjian D., Sefton M.V., Baldwin S.A. Coagulation on biomaterials in flowing blood: some theoretical considerations. Biomaterials. 18:1997;1511-1522.
71. Babensee J.E., Cornelius R.M., Brash J.L., Sefton M.V. Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: human serum proteins in vitro and rat proteins following implantation. Biomaterials. 19:1998;839-849.
72. Horbett T.A., Cheng C.M., Ratner B.D., Hoffman A.S., Hanson S.R. The kinetics of baboon fibrinogen adsorption to polymers: in vitro and in vivo studies. J. Biomed. Mater. Res. 20:1986;739-772.
73. Norman M.E., Williams P., Illum L. In vivo evaluation of protein adsorption to sterically stabilised colloidal carriers. J. Biomed. Mater. Res. 27:1993;861-866.
74. Veerman E.C., Suppers R.J., Klein C.P., de Groot K., Nieuw Amerongen A.V. SDS-PAGE analysis of the protein layers adsorbing in vivo and in vitro to bone substituting materials. Biomaterials. 8:1987;442-448.
75. Buck C.A., Horwitz A.F. Cell surface receptors for extracellular matrix molecules. Annu. Rev. Cell Biol. 3:1987;179-205.
76. Horbett T.A., Schway M.B. Correlations between mouse 3T3 cell spreading and serum fibronectin adsorption on glass and hydroxyethylmethacrylate-ethylmethacrylate copolymers. J. Biomed. Mater. Res. 22:1988;763-793.
77. Jeyanthi R., Rao K.P. In vivo biocompatibility of collagen-poly(hydroxyethyl methacrylate) hydrogels. Biomaterials. 11:1990;238-243.
78. Radder A.M., Davies J.E., Leenders H., van Blitterswijk C.A. Interfacial behavior of PEO/PBT copolymers (Polyactive) in a calvarial system: an in vitro study. J. Biomed. Mater. Res. 28:1994;269-277.
79. Icard P., Penfornis F., Gotheil C., Boillot J., Cornec C., Barrat F., Altman J.J. Tissue reaction to implanted bioartificial pancreas in pigs. Transplant. Proc. 22:1990;724-726.
80. Lanza R.P., Butler D.H., Borland K.M., Staruk J.E., Faustman D.L., Solomon B.A., Muller T.E., Rupp R.G., Maki T., Monaco A.P., et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc. Natl. Acad. Sci. USA. 88:1991;11100-11104.
81. Mazaheri R., Atkison P., Stiller C., Dupre J., Vose J., O'Shea G. Transplantation of encapsulated allogeneic islets into diabetic BB/W rats. Effects of immunosuppression. Transplantation. 51:1991;750-754.
82. Suzuki K., Bonner-Weir S., Hollister-Lock J., Colton C.K., Weir G.C. Number and volume of islets transplanted in immunobarrier devices. Cell Transplant. 7:1998;47-52.
83. Weber C.J., Zabinski S., Koschitzky T., Wicker L., Rajotte R., D'Agati V., Peterson L., Norton J., Reemtsma K. The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice. Transplantation. 49:1990;396-404.
84. Fritschy W.M., de Vos P., Groen H., Klatter F.A., Pasma A., Wolters G.H., van Schilfgaarde R. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transplant Int. 7:1994;264-271.
85. Horcher A., Zekorn T., Siebers U., Klöck G., Frank H., Houben R., Bretzel R.G., Zimmermann U., Federlin K. Transplantation of microencapsulated islets in rats: evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules. Transplant. Proc. 26:1994;784-786.
86. Weber C., Ayres-Price J., Costanzo M., Becker A., Stall A. NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets. Transplant. Proc. 26:1994;1116-1119.
87. Chen C.F., Chern H.T., Leu F.J., Chang T.M., Shian L.R., Sun A.M. Xenotransplantation of microencapsulated canine islets into diabetic rats. Artif. Organs. 18:1994;193-197.
88. Jain K., Yang H., Cai B.R., Haque B., Hurvitz A.I., Diehl C., Miyata T., Smith B.H., Stenzel K., Suthanthiran M., et al. Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression. Transplantation. 59:1995;319-324.
89. Altman J.J., Houlbert D., Callard P., McMillan P., Solomon B.A., Rosen J., Galletti P.M. Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinomas. Diabetes. 35:1986;625-633.
90. Altman J.J., Penfornis A., Boillot J., Maletti M. Bioartificial pancreas in autoimmune nonobese diabetic mice. ASAIO Trans. 34:1988;247-249.
91. Taniguchi H., Fukao K., Nakauchi H. Constant delivery of proinsulin by encapsulation of transfected cells. J. Surg. Res. 70:1997;41-45.
92. Jesser C., Kessler L., Lambert A., Belcourt A., Pinget M. Pancreatic islet macroencapsulation: a new device for the evaluation of artificial membrane. Artif. Organs. 20:1996;997-1007.
93. Kessler L., Jesser C., Lombard Y., Karsten V., Belcourt A., Pinget M., Poindron P. Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: in vivo and in vitro studies. J. Leukocyte Biol. 60:1996;729-736.
94. Wiegand F., Kröncke K.D., Kolb-Bachofen V. Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Protection by arginine analogs and/or coencapsulated erythrocytes. Transplantation. 56:1993;1206-1212.
95. Brauker J., Martinson L.A., Young S.K., Johnson R.C. Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization. Transplantation. 61:1996;1671-1677.
96. Loudovaris T., Mandel T.E., Charlton B. CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells. Transplantation. 61:1996;1678-1684.
97. Weber C., Krekun S., Koschitzky T., Zabinski S., D'Agati V., Hardy M., Reemtsma K. Prolonged functional survival of rat-to-NOD mouse islet xenografts by ultraviolet-B (UV-B) irradiation plus microencapsulation of donor islets. Transplant. Proc. 23:1991;764-766.
98. Fan M.Y., Lum Z.P., Fu X.W., Levesque L., Tai I.T., Sun A.M. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes. 39:1990;519-522.
99. Cole D.R., Waterfall M., McIntyre M., Baird J.D. Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia. 35:1992;231-237.
100. Darquy S., Chicheportiche D., Capron F., Boitard C., Reach G. Comparative study of microencapsulated rat islets implanted in different diabetic models in mice. Horm. Metab. Res. Suppl. 25:1990;209-213.
101. Hallé J.P., Leblond F.A., Pariseau J.F., Jutras P., Brabant M.J., Lepage Y. Studies on small (<300 microns) microcapsules: II - Parameters governing the production of alginate beads by high voltage electrostatic pulses. Cell Transplant. 3:1994;365-372.
102. Lanza R.P., Sullivan S.J., Chick W.L. Perspectives in diabetes. Islet transplantation with immunoisolation. Diabetes. 41:1992;1503-1510.
103. Wijsman J., Atkison P., Mazaheri R., Garcia B., Paul T., Vose J., O'Shea G., Stiller C. Histological and immunopathological analysis of recovered encapsulated allogeneic islets from transplanted diabetic BB/W rats. Transplantation. 54:1992;588-592.
104. Siebers U., Zekorn T., Horcher A., Klöck G., Houben R., Frank H., Bretzel R.G., Zimmermann U., Federlin K. Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients. Transplant Proc. 26:1994;787-788.
105. Xu K., Hercules D.M., Lacík I., Wang T.G. Atomic force microscopy used for the surface characterization of microcapsule immunoisolation devices. J. Biomed. Mater. Res. 41:1998;461-467.
106. Colton C.K., Avgoustiniatos E.S. Bioengineering in development of the hybrid artificial pancreas. J. Biomech. Eng. 113:1991;152-170.
107. Soon-Shiong P., Lu Z.N., Grewal I., Lanza R., Clark W. Prevention of CTL and NK cell-mediated cytotoxicity by microencapsulation. Horm. Metab. Res. Suppl. 25:1990;215-219.
108. Darquy S., Reach G. Immunoisolation of pancreatic B cells by microencapsulation. An in vitro study. Diabetologia. 28:1985;776-780.
109. Kulseng B., Thu B., Espevik T., Skjak-Braek G. Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant. 6:1997;387-394.
110. Goosen M.F.A., O'Shea G.M., Gharapentian A.M., Chou S., Sun A.M. Optimization of microencapsulation parameters: semipermeable microcapsules as a bioartificial pancreas. Biotechnol. Bioeng. 27:1985;146-150.
111. Hallé J.P., Bourassa S., Leblond F.A., Chevalier S., Beaudry M., Chapdelaine A., Cousineau S., Saintonge J., Yale J.F. Protection of islets of Langerhans from antibodies by microencapsulation with alginate-poly-L-lysine membranes. Transplantation. 55:1993;350-354.
112. Coromili V., Chang T.M. Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. Biomater. Artif. Cells Immobilization Biotechnol. 21:1993;427-444.
113. Shimi S.M., Newman E.L., Hopwood D., Cushieri A. Semi-permeable microcapsules for cell culture: ultra-structural characterization. J. Microencapsulation. 8:1991;307-316.
114. Heald K.A., Jay T.R., Downing R. Assessment of the reproducibility of alginate encapsulation of pancreatic islets using the MTT colorimetric assay. Cell Transplant. 3:1994;333-337.
115. Morikawa N., Iwata H., Fujii T., Ikada Y. An immuno-isolative membrane capable of consuming cytolytic complement proteins. J. Biomater. Sci. Polym. Ed. 8:1996;225-236.
116. Date I., Miyoshi Y., Ono T., Imaoka T., Furuta T., Asari S., Ohmoto T., Iwata H. Preliminary report of polymer-encapsulated dopamine-secreting cell grafting into the brain. Cell Transplant. 5:1996;S17-S19.
117. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today. 11:1990;443-449.
118. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and Molecular Immunology. 1997;W.B. Saunders, PA.
119. Říhová B. Biocompatibility of biomaterials: hemocompatibility, immunocompatibility and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers. Adv. Drug Deliv. Rev. 21:1996;157-176.
120. Buscema M., Vinci C., Gatta C., Rabuazzo M.A., Vignen R., Purrello F. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets. Metabolism. 41:1992;296-300.
121. Cirulli V., Halban P.A., Rouiller D.G. Tumor necrosis factor-alpha modifies adhesion properties of rat islet B cells. J. Clin. Invest. 91:1993;1868-1876.
122. Comens P.G., Wolf B.A., Unanue E.R., Lacy P.E., McDaniel M.L. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes. 36:1987;963-970.
123. Kasuga A., Maruyama T., Takei I., Shimada A., Kasatani T., Watanabe K., Saruta T., Nakaki T., Habu S., Miyazaki J. The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines. Diabetologia. 36:1993;1252-1257.
124. Ling Z., In't Veld P.A., Pipeleers D.G. Interaction of interleukin-1 with islet beta-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression. Diabetes. 42:1993;56-65.
125. Pukel C., Baquerizo H., Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes. 37:1988;133-136.
126. Rabinovitch A., Suarez W.L., Thomas P.D., Strynadka K., Simpson I. Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia. 35:1992;409-413.
127. Thu B., Bruheim P., Espevik T., Smidsrod O., Soon-Shiong P., Skjak-Braek G. Alginate polycation microcapsules. II. Some functional properties. Biomaterials. 17:1996;1069-1079.
128. Zimmermann U., Klöck G., Federlin K., Hannig K., Kowalski M., Bretzel R.G., Horcher A., Entenmann H., Sieber U., Zekorn T. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis. 13:1992;269-274.
129. Tai I.T., Vacek I., Sun A. The alginate poly-L-lysine membrane: evidence of a protective effect on microencapsulated islets of Langerhans following exposure to cytokines. Xenotransplant. 2:1995;37-45.
130. Zekorn T., Siebers U., Bretzel R.G., Renardy M., Planck H., Zschocke P., Federlin K. Protection of islets of Langerhans from interleukin-1 toxicity by artificial membranes. Transplantation. 50:1990;391-394.